Biologic markers in breast carcinoma. IV. Serum fucose‐protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophin

Cancer

Volumn 41, Issue 5, 1978, Pages 1871-1882

  Waalkes, T Phillip ^a   Gehrke, Charles W ^b   Tormey, Douglass C ^c   Woo, Kwang B ^d   Kuo, Kenneth C ^b   Snyder, Jack ^e   Hansen, Hans ^e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; FUCOSE; PROTEIN; RADIOISOTOPE;

BREAST; BREAST CARCINOMA; DIAGNOSIS; MAJOR CLINICAL STUDY;

BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; FEMALE; FUCOSE; HUMANS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RECURRENCE; REMISSION, SPONTANEOUS;

EID: 0018138505     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(197805)41:5<1871::AID-CNCR2820410531>3.0.CO;2-V     Document Type: Article

References (34)

1. A study of serum glycoproteins in cancer
2. Tumors and serum glycoproteins. The “Symbodies”
3. Serum Protein‐bound fucose in patients with gynecologic cancers
4. Concomitant elevations in serum sialyltransferase activity and sialic acid content in rats with metastasizing mammary tumors
5. Uridine 5′‐diphosphate‐galactose: Glycoprotein galactosyl‐transferase activity in the ovarian cancer patient
6. Elevations in serum glycoprotein: N‐Acetylneuraminic acid transferases in rats bearing mammary tumors
7. The occurrence of β‐galactosyltransferase in normal human urine
8. Evaluation of carcinoem‐bryonic antigen in human mammary carcinoma
9. Utility of serum protein‐bound neutral hexoses and L‐fucose for estimation of malignant tumor extension and evaluation of efficacy of therapy
10. Human chorionic gonadotrophins (hCG) in non‐trophoblastic neoplasms
11. Determination of serum proteins by means of the biuret reaction
12. The diagnostic value of protein‐bound serum fucose in cancer of the breast
13. Carcino‐embryonic antigen (CEA) assay
14. Serum glycoproteins in infections and inflammatory diseases
15. Alterations in plasma sialyltransferase associated with successful chemotherapy of a disseminated tumor
16. Plasma glycoproteins in various disease states including carcinoma
17. Plasma glycoproteins and malignant disease
18. Serum protein‐bound fucose in patients with breast masses
19. Protein‐bound carbohydrates in breast cancer. Liquid‐chromatographic analysis for mannose, galaclose, fucose, and sialic acid in serums
20. Liquid‐chromatographic analysis of neutral carbohydrates in serum glycoproteins
21. Serum glycoproteins in the evaluation of breast cancer
22. Serum protein‐bound fucose and carcinoma of the female breast
23. Serum fucose in the diagnosis of breast cancer
24. Serum protein‐bound fucose levels in certain chronic diseases. A clinical‐statistical study
25. Serum glycoproteins: Their origin and significance
26. The serum polysaccharide level in malignancy and in other pathological conditions
27. Quantitation of specific serum glycoproteins in malignancy
28. Glycoproteins: Their biochemistry, biology and role in human disease
29. Carcinoembryonic antigen in breast cancer patients: Serum levels and disease progress
30. Biological markers in breast carcinoma. I. Incidence of abnormalities of CEA, hCG, three polyamines and three minor nucleosides
31. Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophin
32. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen
33. A radioimmunoassay which specifically measures human chorionic gonadotrophin in the presence of human luteinizing hormone
34. Determination of serum glycoproteins